Your browser doesn't support javascript.
loading
Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
Matsunaga, Toshiyuki; Morikawa, Yoshifumi; Haga, Mariko; Endo, Satoshi; Soda, Midori; Yamamura, Keiko; El-Kabbani, Ossama; Tajima, Kazuo; Ikari, Akira; Hara, Akira.
Afiliação
  • Matsunaga T; Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan. Electronic address: matsunagat@gifu-pu.ac.jp.
  • Morikawa Y; Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Haga M; Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Endo S; Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Soda M; Laboratory of Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya 464-8650, Japan.
  • Yamamura K; Laboratory of Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya 464-8650, Japan.
  • El-Kabbani O; Monash Institute of Pharmaceutical Sciences, Monash University, Victoria 3052, Australia.
  • Tajima K; Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa 920-1181, Japan.
  • Ikari A; Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Hara A; Faculty of Engineering, Gifu University, Gifu 501-1193, Japan.
Toxicol Appl Pharmacol ; 278(2): 180-9, 2014 Jul 15.
Article em En | MEDLINE | ID: mdl-24813866
ABSTRACT
Inhalation of 9,10-phenanthrenequinone (9,10-PQ), a major quinone in diesel exhaust, exerts fatal damage against a variety of cells involved in respiratory function. Here, we show that treatment with high concentrations of 9,10-PQ evokes apoptosis of lung cancer A549 cells through production of reactive oxygen species (ROS). In contrast, 9,10-PQ at its concentrations of 2 and 5 µM elevated the potentials for proliferation, invasion, metastasis and tumorigenesis, all of which were almost completely inhibited by addition of an antioxidant N-acetyl-l-cysteine, inferring a crucial role of ROS in the overgrowth and malignant progression of lung cancer cells. Comparison of mRNA expression levels of six aldo-keto reductases (AKRs) in the 9,10-PQ-treated cells advocated up-regulation of AKR1B10 as a major cause contributing to the lung cancer malignancy. In support of this, the elevation of invasive, metastatic and tumorigenic activities in the 9,10-PQ-treated cells was significantly abolished by the addition of a selective AKR1B10 inhibitor oleanolic acid. Intriguingly, zymographic and real-time PCR analyses revealed remarkable increases in secretion and expression, respectively, of matrix metalloproteinase 2 during the 9,10-PQ treatment, and suggested that the AKR1B10 up-regulation and resultant activation of mitogen-activated protein kinase cascade are predominant mechanisms underlying the metalloproteinase induction. In addition, HPLC analysis and cytochrome c reduction assay in in vitro 9,10-PQ reduction by AKR1B10 demonstrated that the enzyme catalyzes redox-cycling of this quinone, by which ROS are produced. Collectively, these results suggest that AKR1B10 is a key regulator involved in overgrowth and malignant progression of the lung cancer cells through ROS production due to 9,10-PQ redox-cycling.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenantrenos / Regulação para Cima / Aldeído Redutase / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenantrenos / Regulação para Cima / Aldeído Redutase / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article